Celltrion nabs emergency use for rapid COVID-19 test from FDA

Celltrion has nabbed a speedy preapproval for its quick pandemic virus test as it forecasts high demand. This comes three months after asking the FDA for an emergency use authorization, which has been giving COVID-19 tests and drugs the ability to be used in the U.S. but is not a full approval.